Optase

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Optase
Generic name: GLYCERIN
Manufacturer: Scope Health Inc
Product type: HUMAN OTC DRUG
SPL set ID: d81c1a4f-87b0-ee8c-e053-2995a90af9e5
SPL ID: 49a62bc6-5b72-db88-e063-6294a90ae6cc
Version: 5
Effective date: 2026-01-30
Source export date: 2026-09-28
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:27:02

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M018	openfda.application_number
brand name		Optase	openfda.brand_name
generic name		GLYCERIN	openfda.generic_name
manufacturer name		Scope Health Inc	openfda.manufacturer_name
ndc	package	72972-004-01	openfda.package_ndc
ndc	product	72972-004	openfda.product_ndc
ndc11	package	72972000401	derived:openfda.package_ndc
rxcui		2593715	openfda.rxcui
spl id		49a62bc6-5b72-db88-e063-6294a90ae6cc	id
spl set id		d81c1a4f-87b0-ee8c-e053-2995a90af9e5	set_id
unii		PDC6A3C0OX	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning • For external use only. • To avoid contamination, do not touch tip of container to any surface. After use, shake the bottle downwards in order to remove any residual drop that may be left. Replace cap after using. • Do not use the solution if it changes color or becomes cloudy Stop use and ask doctor if • You feel eye pain. • Changes in vision occur. • Redness or irritation of the eye lasts. • Condition worsens or lasts more than 72 hours.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.